1. Home
  2. LMNR vs CGEN Comparison

LMNR vs CGEN Comparison

Compare LMNR & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$13.30

Market Cap

233.9M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.86

Market Cap

188.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
CGEN
Founded
1893
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
188.2M
IPO Year
2005
2001

Fundamental Metrics

Financial Performance
Metric
LMNR
CGEN
Price
$13.30
$2.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$20.00
$5.00
AVG Volume (30 Days)
87.2K
280.7K
Earning Date
03-12-2026
05-18-2026
Dividend Yield
2.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$159,723,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.95
$112.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.20
$1.23
52 Week High
$17.11
$2.78

Technical Indicators

Market Signals
Indicator
LMNR
CGEN
Relative Strength Index (RSI) 48.55 79.22
Support Level $12.73 $1.45
Resistance Level $14.86 N/A
Average True Range (ATR) 0.41 0.15
MACD -0.00 0.07
Stochastic Oscillator 57.46 92.19

Price Performance

Historical Comparison
LMNR
CGEN

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: